Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Dietrich

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|February 28, 2014
Davis and Dietrich's response to Abramson and colleagues' article on statins in low risk peopleKyle A Davis, Eric Dietrich
Case Reports in Medicine|July 9, 2019
Effects of Oral Ginger Supplementation on the INRDaniel Rubin, Vishal Patel, Eric Dietrich
Cognitive Science|May 19, 2011
Explanatory pluralism in cognitive scienceRick Dale, Eric Dietrich, Anthony Chemero
Drug Design, Development and Therapy|November 29, 2013
Canagliflozin: a novel treatment option for type 2 diabetesEric Dietrich, Jason Powell, James R Taylor
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 22, 2013
Lorcaserin for weight managementJames R Taylor, Eric Dietrich, Jason Powell
Journal of Managed Care & Specialty Pharmacy|March 26, 2026
Shared visits vs incident-to billing for pharmacy servicesEric Dietrich, Elaina Rosario, Sara M Panella
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2019
Risk of Daptomycin-associated Myopathy With Concomitant Statin UseJustin A Wasko, Eric Dietrich, Kyle Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 20, 2015
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidenceKyle A Davis, Marta A Miyares, Eric Dietrich
Therapeutic Advances in Drug Safety|December 7, 2019
Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulationElise Carpenter, Divita Singh, Eric Dietrich, et al.
Clinical Therapeutics|January 19, 2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesityJames R Taylor, Eric Dietrich, Jason G Powell
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|February 28, 2014
Davis and Dietrich's response to Abramson and colleagues' article on statins in low risk peopleKyle A Davis, Eric Dietrich
Case Reports in Medicine|July 9, 2019
Effects of Oral Ginger Supplementation on the INRDaniel Rubin, Vishal Patel, Eric Dietrich
Cognitive Science|May 19, 2011
Explanatory pluralism in cognitive scienceRick Dale, Eric Dietrich, Anthony Chemero
Drug Design, Development and Therapy|November 29, 2013
Canagliflozin: a novel treatment option for type 2 diabetesEric Dietrich, Jason Powell, James R Taylor
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 22, 2013
Lorcaserin for weight managementJames R Taylor, Eric Dietrich, Jason Powell
Journal of Managed Care & Specialty Pharmacy|March 26, 2026
Shared visits vs incident-to billing for pharmacy servicesEric Dietrich, Elaina Rosario, Sara M Panella
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2019
Risk of Daptomycin-associated Myopathy With Concomitant Statin UseJustin A Wasko, Eric Dietrich, Kyle Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 20, 2015
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidenceKyle A Davis, Marta A Miyares, Eric Dietrich
Therapeutic Advances in Drug Safety|December 7, 2019
Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulationElise Carpenter, Divita Singh, Eric Dietrich, et al.
Clinical Therapeutics|January 19, 2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesityJames R Taylor, Eric Dietrich, Jason G Powell
Pageof 5